BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Devulapally R, Lee T, Barghava-Shah A, et al. (2018) Ultrasound-guided delivery of thymidine kinase-nitroreductase dual therapeutic genes by PEGylated-PLGA/PIE nanoparticles for enhanced triple negative breast cancer therapy. Nanomedicine (London, England) |
| Devulapally R, Foygel K, Sekar TV, et al. (2016) Gemcitabine and Antisense-microRNA Co-encapsulated PLGA-PEG Polymer Nanoparticles for Hepatocellular Carcinoma Therapy. Acs Applied Materials & Interfaces. 8: 33412-33422 |
| Oronsky B, Paulmurugan R, Foygel K, et al. (2016) RRx-001: A Systemically Non-Toxic M2-to-M1 Macrophage Stimulating and Prosensitizing Agent In Phase II Clinical Trials. Expert Opinion On Investigational Drugs |
| Sekar TV, Foygel K, Devulapally R, et al. (2016) Molecular Imaging Biosensor Monitors p53 Sumoylation in Cells and Living Mice. Analytical Chemistry. 88: 11420-11428 |
| Calibasi Kocal G, Güven S, Foygel K, et al. (2016) Dynamic Microenvironment Induces Phenotypic Plasticity of Esophageal Cancer Cells Under Flow. Scientific Reports. 6: 38221 |
| Sekar TV, Foygel K, Massoud TF, et al. (2016) A transgenic mouse model expressing an ERα folding biosensor reveals the effects of Bisphenol A on estrogen receptor signaling. Scientific Reports. 6: 34788 |
| Bhargava-Shah A, Foygel K, Devulapally R, et al. (2016) Orlistat and antisense-miRNA-loaded PLGA-PEG nanoparticles for enhanced triple negative breast cancer therapy. Nanomedicine (London, England). 11: 235-47 |
| Kumar V, Foygel K, Paulmurugan R, et al. (2016) Abstract 1363: Novel Nrf2 inhibitors and their application to overcome chemoresistance of anticancer drugs Cancer Research. 76: 1363-1363 |
| Paulmurugan R, Bhethanabotla R, Mishra K, et al. (2015) Folate Receptor Targeted Polymeric Micellar Nanocarriers for Delivery of Orlistat as a Repurposed Drug against Triple Negative Breast Cancer. Molecular Cancer Therapeutics |
| Foygel K, Sekar TV, Paulmurugan R. (2015) Monitoring the Antioxidant Mediated Chemosensitization and ARE-Signaling in Triple Negative Breast Cancer Therapy. Plos One. 10: e0141913 |